Immatics (IMTX) Change in Intangibles (2019 - 2025)
Immatics' (IMTX) quarterly Change in Intangibles came in at -$66350.5 in Q4 2025, down 3.49% year-on-year from -$68746.6 in Q4 2024, and up 54.91% quarter-over-quarter from -$147154.8 in Q2 2025.
Immatics (IMTX) Change in Intangibles (2019 - 2025) Analysis & Trends
Immatics has disclosed Change in Intangibles across 7 years of filings, most recently posting -$66350.5 for Q4 2025.
- Change in Intangibles for Q4 2025 came in at -$66350.5, down 3.49% year-over-year; the trailing twelve-month figure through Dec 2025 was -$276618.3 (down 23.76% YoY), and the FY2025 annual result was -$279063.4, down 25.55% from the prior year.
- Change in Intangibles came in at -$66350.5 for Q4 2025 at Immatics, up from -$147154.8 in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of $169828.5 in Q4 2023 to a low of -$462440.2 in Q2 2021.
- The 5-year median for Change in Intangibles is -$65233.1 (2024), against an average of -$91333.2.
- Peak annual rise in Change in Intangibles reached 164.77% in 2023, while the deepest fall reached 3624.8% in 2023.
- Immatics' Change in Intangibles stood at -$73214.1 in 2021, then plunged by 258.13% to -$262203.6 in 2022, then jumped by 164.77% to $169828.5 in 2023, then sank by 137.75% to -$64115.7 in 2024, then declined by 3.49% to -$66350.5 in 2025.
- The last three Change in Intangibles figures came in at -$66350.5 (Q4 2025), -$147154.8 (Q2 2025), and -$63113.1 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | -66,350.48 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -66,350.48 |
| Dec 31, 2025 | -66,350.48 |
| Jun 30, 2025 | -147,154.76 |
| Jun 30, 2025 | -147,154.76 |
| Mar 31, 2025 | -63,113.07 |
| Mar 31, 2025 | -63,113.07 |
| Dec 31, 2024 | -64,115.72 |
| Dec 31, 2024 | -64,115.72 |
| Jun 30, 2024 | -157,225.59 |
| Jun 30, 2024 | -157,225.59 |
| Mar 31, 2024 | -2,172.72 |
| Mar 31, 2024 | -2,172.72 |
| Dec 31, 2023 | 169,828.51 |
| Dec 31, 2023 | 169,828.51 |
| Sep 30, 2023 | -4,354.36 |
| Sep 30, 2023 | -4,354.36 |
| Jun 30, 2023 | -158,982.96 |
| Jun 30, 2023 | -158,982.96 |
| Mar 31, 2023 | -8,586.73 |
| Mar 31, 2023 | -8,586.73 |